STRATA Skin Sciences, Inc. SSKN Cash Flow

Strata skin sciences, inc. (SSKN)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12
Cash Flows From Operating Activities:
Net loss
-1,035	-515	-860	-1,082	-1,333	285	-608	-1,629	-2,081	-4,403	-13,671	534	-3,974	-887	-1,509	498	-1,437	-593	-9,234	-7,848	-7,272	-4,504	-2,288	627	-7,980	-4,610	-7,404	-7,421	-6,511	-6,078	-5,356	-5,484	-5,753
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization
1,038	1,066	1,090	1,143	1,204	1,254	1,302	1,378	1,463	1,525	1,602	1,666	1,543	1,522	1,521	1,639	1,684	1,703	1,707	325	316	419	490	184	696	648	683	610	496	386	252	182	148
Amount of amortization expense attributable to right-of-use asset from operating lease.
79	78	93	54	93	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Provision for doubtful accounts
2	34	7	9	-7	-83	102	-49	0	51	36	22	0	29	6	45	40	0	20	-1	1	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of property and equipment and lasers placed in service
0	29	-7	0	-22	96	-92	-229	-182	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Refers to gain (loss) on cancelation of distributor rights agreement.
-	-	-	-	-	0	0	237	-226	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment of intangible assets
-	-	-	-	-	-	-	-	-	0	23	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bad debt expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-6	11	0	40	-	-	-	-
Write-off of unamortized financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	0	0	41	-	-	-	-
Stock-based compensation
430	312	257	303	323	334	367	184	19	50	63	21	52	-288	115	116	170	270	1,007	246	230	-34	115	167	164	44	159	828	268	381	331	426	347
Deferred taxes
88	0	-22	-47	-42	-281	-102	40	40	-125	60	60	60	60	60	60	60	119	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Loss on extinguishment of debentures
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount
0	-	31	5	7	-	5	20	19	-1,400	726	1,371	247	652	582	600	639	908	4,909	647	2,015	1,558	385	0	0	-	-	-	-	-	-	-	-
Amortization of deferred financing costs
0	-	7	30	27	-	37	22	20	17	56	61	54	55	54	43	48	18	154	39	180	153	38	0	0	-	-	-	41	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	79	23	-1	-518	-81	-667	671	-80	-132	-3,199	-1,985	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of embedded conversion feature
-	-	-	-	-	-	-	-	-	-	-	-	-1,738	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	84	14	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,985	-1,334	952	2,108	4,905	137	-206	0	-105	15	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
-1,176	775	176	-90	175	583	349	-60	-650	-54	-277	249	-102	483	234	-493	-782	-114	539	-25	-214	186	36	15	-22	-0	-145	39	29	79	32	56	12
Inventories
444	-559	-21	486	327	306	75	-616	20	-523	46	817	-147	-412	-525	-398	24	213	506	-98	-113	-578	1,985	-639	16	-41	-4	164	-238	109	183	73	310
Prepaid expenses and other assets
-43	-28	-118	184	-142	246	-159	-373	669	-69	-163	-431	188	-22	-34	-80	-88	-182	384	-139	76	-344	285	-132	-414	214	-82	-129	-89	255	-44	-151	-155
Accounts payable
222	-117	-94	46	281	101	281	-1,276	381	310	-332	49	354	-46	-725	-879	-955	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable and accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	253	85	314	-110	-201	863	-710	-192	19	-728	1,059	-834	616	-114	813	75
Other accrued liabilities
16	197	189	24	224	252	757	13	-16	764	-47	-189	74	454	63	-163	-523	242	-196	54	-8	-	-	-	-	-	-	-	-	-	-	-	-
Other liabilities
-59	-149	-56	-14	9	-57	-258	28	227	51	24	48	36	76	7	-12	-35	-41	-19	-10	-10	-112	86	-13	-6	9	4	-6	19	-40	38	-1	13
The increase (decrease) during the reporting period in the aggregate amount of lease liabilities that result from activities that generate operating income.
-60	-22	-93	-50	-76	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenues
-898	349	191	229	-36	400	74	77	-380	-473	-63	276	-98	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-10	-6	-5	-5	-5	1	1	1	1
Deferred revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-92	123	-21	52	-94	-106	147	-28	0	-97	-64	-76	-65	-61	41	88	152	62	70	17
Net cash provided by operating activities
598	1,113	710	70	336	1,101	1,863	-128	60	1,894	549	879	818	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4,955	-3,913	-5,316
Cash Flows From Investing Activities:
Long-term interest payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	34	44	7	-	-	-	-
Net cash provided by (used in) operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,396	375	-1,390	-2,454	-3,101	-3,041	-3,629	-3,918	-7,120	-3,899	-5,008	-4,412	-6,092	-	-	-	-
The cash inflow (outflow) for Lasers placed in service.
596	1,306	423	513	434	495	369	510	375	289	245	522	683	401	279	131	197	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of property and equipment
-	-	-	-	-	7	0	0	6	-1	115	6	200	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Refers to cash outflows associated with the payments of distributor rights liability.
-	-	-	-	-	0	0	-1	24	20	40	75	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	6,000	-	-	-	-
Expenses related to issuance of Series B convertible preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-245	0	0	245	-	-	-	-
Net cash used in investing activities
-596	-1,416	-423	-518	-434	-502	-369	-509	-405	-308	-400	-603	-883	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,277	-982	-408
Cash Flows From Financing Activities:
The cash outflow for advance fees related to equity financing.
-	-	-	-	-	-	-	-	202	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11,460	5,384	0	43	15,746	-	-	-	-
Lasers placed-in-service, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-15	-85	0	0	100	0	0	0	0	-	-	-	-	-	-	-	-
Offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	105	194	4
Purchases of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	322	1,099	2,124	1,641	2,489	2,277	982	408
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-182	-556	-960	-42,623	-100	0	11	6	0	-322	-1,099	-2,124	-1,641	-	-	-	-
Proceeds from long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	1,500	10,500	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Expenses related to borrowings and issuance of warrant
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	245	-	-	-	-
Repayments of long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments on notes payable
-	-	-	-	-	-	51	201	105	70	103	101	100	34	92	102	105	73	15	5	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash (used in) provided by financing activities
-	-	-	-	-	0	-51	11,665	-307	-642	-960	-101	-100	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,298	-194	29
Proceeds from exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	0	0	18	6	5	0	33
Net cash (used in ) provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,395	324	-49	42,395	0	8	13,883	-8	11,460	5,384	-6,425	43	21,519	-	-	-	-
Net (decrease) increase in cash and cash equivalents and restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-165	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents and restricted cash
2	-	287	-448	-98	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net decrease in cash and cash equivalents
-	-	-	-	-	-	-	-	-652	-	-	-	-	971	116	-279	-183	134	-2,384	-2,680	-3,201	-3,033	10,265	-3,920	4,339	1,162	-12,532	-6,494	13,785	-5,413	-3,935	-5,090	-5,695
Supplemental information of cash and non-cash transactions:
Cash paid for interest
52	162	200	203	201	201	117	415	276	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	442	786	152	111	139	116	0	0	0	-	-	-	-	-	-	-	-
The cash inflow (outflow) for lease liabilities arising from obtaining right-of-use assets.
0	0	0	784	848	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of senior secured convertible debentures into common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	17	0	83	165	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Recognition of warrants issued as debt discount
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	47	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of senior secured convertible debentures into common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,308	1,589	0	0	0	-	-	-	-	-	-	-	-
Conversion of series A convertible preferred stock into common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	3,775	1,508	-	-	0	0	-	-	-	-	-	-	-	-
Reclassification of MelaFind components from other assets to property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0	0	0	522
Reclassification of property and equipment to inventory, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	81	26	0	0	0	0	-	-	-	-	-	-	-	-
The amount of debt that an entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. noncash is defined as transactions during a period that affect recognized asset and liabilities license.
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-